Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2011-11-01
Source
PubMed
DOI
10.1177/0269881110382466
PubMed
20855349
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:28 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients2026-11-10Caution before canonisation: a clinical and implementation science perspective on psychedelics2026-10-05The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies2026-08-18Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression2026-04-09A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience2025-11-30Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway2025-10-01Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats2025-09-01The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin2025-08-08Explore the effect of psilocybin on depression and anxiety2025-07-06Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review2025-05-02Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung2025-05-01Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?2025-01-21The many faces of psilocybin-related psychosis: A case series2024-12-07Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare2024-06-28The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review2023-11-29Psilocybin Use in Palliative Care #4642023-09-01Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions2022-06-09Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication2021-10-13Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa2021-06-24The need for publicly funded research on therapeutic use of psychedelic drugs2021-05-18

Related papers